Ray Dalio Medical Devices

Bridgewater Associates, LP

$21.1 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
MDT Medtronic PLC	$123B	$40.8 Million 0.19% of portfolio	511,349	Q4 2024 Reduced 12.25%
ABT Abbott Laboratories	$231B	$21.7 Million 0.1% of portfolio	191,726	Q4 2024 Reduced 72.91%
ZBH Zimmer Biomet Holdings, Inc.	$21B	$21.2 Million 0.1% of portfolio	200,493	Q4 2024 Added 11.0%
BSX Boston Scientific Corp	$152B	$14.6 Million 0.07% of portfolio	162,913	Q4 2024 Reduced 54.34%
SYK Stryker Corp	$147B	$14.4 Million 0.07% of portfolio	39,865	Q4 2024 Reduced 32.7%
EW Edwards Lifesciences Corp	$47B	$8.02 Million 0.04% of portfolio	108,285	Q4 2024 Reduced 34.55%
DXCM Dexcom Inc	$32.5B	$7.62 Million 0.04% of portfolio	97,938	Q4 2024 Reduced 69.36%
SNN Smith & Nephew PLC	$11.2B	$4.09 Million 0.02% of portfolio	166,403	Q4 2024 Added 79.68%
STE Steris PLC	$21.9B	$2.25 Million 0.01% of portfolio	10,968	Q4 2024 Reduced 30.32%
PODD Insulet Corp	$19.6B	$2.02 Million 0.01% of portfolio	7,730	Q4 2024 Reduced 30.62%
ALGN Align Technology Inc	$16B	$1.58 Million 0.01% of portfolio	7,566	Q4 2024 Reduced 78.63%
PEN Penumbra Inc	$10.3B	$947,000 0.0% of portfolio	3,990	Q4 2024 Reduced 31.08%
GKOS Glaukos Corp	$6.97B	$872,000 0.0% of portfolio	5,820	Q4 2024 Reduced 30.5%
INSP Inspire Medical Systems, Inc.	$5.39B	$586,000 0.0% of portfolio	3,162	Q4 2024 Reduced 30.35%
ITGR Integer Holdings Corp	$4.59B	$467,000 0.0% of portfolio	3,529	Q4 2024 Reduced 30.64%
IRTC I Rhythm Technologies, Inc.	$3.37B	$303,000 0.0% of portfolio	3,364	Q4 2024 Reduced 65.86%
NARI Inari Medical, Inc.	$4.27B	$292,000 0.0% of portfolio	5,730	Q4 2024 Reduced 30.19%
TNDM Tandem Diabetes Care Inc	$2.09B	$265,000 0.0% of portfolio	7,378	Q4 2024 Reduced 71.22%
TMDX Trans Medics Group, Inc.	$2.27B	$215,000 0.0% of portfolio	3,463	Q4 2024 Reduced 28.92%
UFPT Ufp Technologies Inc	$1.92B	$203,000 0.0% of portfolio	831	Q4 2024 Reduced 75.47%
AHCO Adapt Health Corp.	$1.2B	$111,000 0.0% of portfolio	11,675	Q4 2024 Reduced 71.34%

Shares Options

Ray Dalio

Ray Dalio is the founder and co-chief investment officer of Bridgewater Associates, one of the largest and most successful investment firms in the world. Dalio is known for his expertise in macroeconomic investing and his principles-based approach to decision making. He is also a well-known philanthropist and author.

Track Ray Dalio's portfolio

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account